Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease

The Egyptian Rheumatologist 2026

View at publisher

Authors: Nada M. Gamal, E.-S. A. M. Badawy, Dalia Mohamed Aly Tohamy, Esraa Ahmed Talaat

DOI: 10.1016/j.ejr.2026.01.003

Cited by: 0

References: 39

Fields of Study & Subjects

Ocular Diseases and Behçet’s Syndrome Sarcoidosis and Beryllium Toxicity Research Spondyloarthritis Studies and Treatments

References 39